Evidence map›Paper›PMID 28603504›Full record

ReviewFrontiers in psychiatry2017

The Safety of Ingested Caffeine: A Comprehensive Review.

Jennifer L Temple, Christophe Bernard, Steven E Lipshultz, Jason D Czachor, Joslyn A Westphal, Miriam A Mestre

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06359197 (Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease), which is not on this map. Cited by 209 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
209citing papers in PubMed, 8 pooled it
25.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06359197 early_phase1unknown statusnot on this mapstarted 2024, after this paper: background citation

Feasibility Study for Investigating the Effect of Caffeine Consumption on Protein Biomarkers Related to Cardiovascular Disease

TypeinterventionalSponsorHamilton Health Sciences CorporationRan2024 to 2025Enrolled36ConditionsHealthyArmsCaffeine Pill, Placebo, TASSO+ Device, Finger prick and collection on Whatman Protein 903 Saver Cards, Intravenous Sampling
3 · Its place in the literature

Who cites it

209 citing papers in PubMed, 8 syntheses or guidelines pooled it, 523 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Caffeine's influence on vertical jump height: a real-life collegiate student-athlete approach.Journal of the International Society of Sports Nutrition · 2025
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

149 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jennifer L TempleDepartment of Exercise and Nutrition Sciences, University at Buffalo, Buffalo, NY, USA.
Christophe BernardAix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France.
Steven E LipshultzWayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI, USA.
Jason D CzachorWayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI, USA.
Joslyn A WestphalWayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI, USA.
Miriam A MestreWayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI, USA.
Wayne State University · USChildren's Hospital of Michigan · USInserm · FRUniversity at Buffalo, State University of New York · US

Funding

Zebrafish Screens for Genetic Modifiers and Human Application in T-ALLP01CA068484 · NCI · DANA-FARBER CANCER INSTITUTE · PI KUTOK, JEFFERY LORNE · 1995 to 2010
$31.9M
Pediatric HIV/AIDS Cohort Study (PHACS): Understanding Maternal HIV Disease through Pregnancy and the Postpartum Period and its Role in Child Health OutcomesU01HD052104 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI VAN DYKE, RUSSELL B. · 2005 to 2019
$15.7M
Genotype-Phenotype Associations in Pediatric CardiomyopathyR01HL111459 · NHLBI · WAYNE STATE UNIVERSITY · PI LIPSHULTZ, STEVEN EDWARD · 2012 to 2015
$8.6M
PEDIATRIC CARDIOMYOPATHY REGISTRYR01HL053392 · NHLBI · UNIVERSITY OF ROCHESTER · PI LIPSHULTZ, STEVEN EDWARD · 1995 to 2009
$8.3M
Cardiac Biomarkers in Pediatric CardiomyopathyR01HL109090 · NHLBI · WAYNE STATE UNIVERSITY · PI ROSS, ROBERT D. · 2012 to 2016
$5.3M
Mitochondrial Determinants of Metabolic Disease in HIV-Infected ChildrenR01NR012885 · NINR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GERSCHENSON, MARIANA, MILLER, TRACIE L · 2010 to 2014
$2.5M
Pediatric Cardiomyopathy Specimen RepositoryR01HL087000 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI TOWBIN, JEFFREY ALLEN · 2007 to 2010
$2.2M
HAART Associated Cardiotoxicity in HIV-Infected ChildrenR01HL078522 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIPSHULTZ, STEVEN EDWARD · 2004 to 2008
$2.0M
Sensitization of the reinforcing value of food as a predictor of weight change in adolescentsR01DK106265 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI TEMPLE, JENNIFER L · 2016 to 2020
$1.9M
Gender Differences in Responses to Caffeine in Children and AdolescentsR01DA030386 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI TEMPLE, JENNIFER L · 2011 to 2015
$1.7M
Atherosclerotic Risk and Response to Exercise Intervention in HIV+ ChildrenR01HL095127 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MILLER, TRACIE L · 2008 to 2010
$1.1M
Dietary Intakes and patterns, biomarkers, and maternal and infant outcomes in HIVR01HD060325 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JACOBSON, DENISE L., MILLER, TRACIE L · 2009 to 2010
$1.0M
NCI NIH HHS P01 CA068484NCI NIH HHS R01 CA127642NHLBI NIH HHS R01 HL053392NHLBI NIH HHS R01 HL078522NHLBI NIH HHS R01 HL087000NHLBI NIH HHS R01 HL095127NHLBI NIH HHS R01 HL109090NHLBI NIH HHS R01 HL111459NICHD NIH HHS R01 HD060325NICHD NIH HHS U01 HD052104NIDA NIH HHS K01 DA021759NIDA NIH HHS R01 DA030386NIDDK NIH HHS R01 DK106265NINR NIH HHS R01 NR012885
6 · The paper itself

Abstract

Caffeine is the most widely consumed psychoactive drug in the world. Natural sources of caffeine include coffee, tea, and chocolate. Synthetic caffeine is also added to products to promote arousal, alertness, energy, and elevated mood. Over the past decade, the introduction of new caffeine-containing food products, as well as changes in consumption patterns of the more traditional sources of caffeine, has increased scrutiny by health authorities and regulatory bodies about the overall consumption of caffeine and its potential cumulative effects on behavior and physiology. Of particular concern is the rate of caffeine intake among populations potentially vulnerable to the negative effects of caffeine consumption: pregnant and lactating women, children and adolescents, young adults, and people with underlying heart or other health conditions, such as mental illness. Here, we review the research into the safety and safe doses of ingested caffeine in healthy and in vulnerable populations. We report that, for healthy adults, caffeine consumption is relatively safe, but that for some vulnerable populations, caffeine consumption could be harmful, including impairments in cardiovascular function, sleep, and substance use. We also identified several gaps in the literature on which we based recommendations for the future of caffeine research.

Indexed as

adolescencecaffeinechildrenenergy drinkspregnancy

Identifiers

PMID28603504
PMCPMC5445139
OpenAlexW2618570363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.